UBS AM’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.4M | Buy |
|
|||||
|
2025
Q1 | $20.9M | Sell |
|
|||||
|
2024
Q4 | $16.7M | Sell |
|
|||||
|
2024
Q3 | $16.8M | Sell |
|
|||||
|
2024
Q2 | $17.9M | Buy |
|
|||||
|
2024
Q1 | $19.8M | Sell |
|
|||||
|
2023
Q4 | $26.7M | Sell |
|
|||||
|
2023
Q3 | $18.3M | Sell |
|
|||||
|
2023
Q2 | $11.7M | Hold |
|
|||||
|
2023
Q1 | $11.7M | Buy |
|
|||||
|
2022
Q4 | $792K | Sell |
|
|||||
|
2022
Q3 | $1.07M | Buy |
|
|||||
|
2022
Q2 | $769K | Buy |
|
|||||
|
2022
Q1 | $664K | Buy |
|
|||||
|
2021
Q4 | $1.08M | Sell |
|
|||||
|
2021
Q3 | $3.31M | Buy |
|
|||||
|
2021
Q2 | $4.22M | Buy |
|
|||||
|
2021
Q1 | $2.43M | Sell |
|
|||||
|
2020
Q4 | $11.8M | Sell |
|
|||||
|
2020
Q3 | $6.54M | Sell |
|
|||||
|
2020
Q2 | $5.77M | Buy |
|
|||||
|
2020
Q1 | $4.9M | Buy |
|
|||||
|
2019
Q4 | $2.69M | Sell |
|
|||||
|
2019
Q3 | $1.65M | Buy |
|
|||||
|
2019
Q2 | $2.02M | Buy |
|